Pro-Dex, Inc. (PDEX)
USD 54.97
(3.97%)
USD 54.97
(3.97%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 10.91 Million USD | -7.93% |
| 2023 | 11.85 Million USD | -19.57% |
| 2022 | 14.74 Million USD | 28.37% |
| 2021 | 11.48 Million USD | 4265.78% |
| 2020 | 263 Thousand USD | 108.25% |
| 2019 | -3.18 Million USD | 38.1% |
| 2018 | -5.14 Million USD | -25.97% |
| 2017 | -4.08 Million USD | -83.89% |
| 2016 | -2.22 Million USD | -272.82% |
| 2015 | -596 Thousand USD | 81.22% |
| 2014 | -3.17 Million USD | -91.14% |
| 2013 | -1.66 Million USD | 50.27% |
| 2012 | -3.33 Million USD | 6.18% |
| 2011 | -3.55 Million USD | -295.77% |
| 2010 | -899 Thousand USD | -140.79% |
| 2009 | 2.2 Million USD | -36.47% |
| 2008 | 3.46 Million USD | 60.45% |
| 2007 | 2.16 Million USD | -29.9% |
| 2006 | 3.08 Million USD | 219.35% |
| 2005 | -2.58 Million USD | -34.23% |
| 2004 | -1.92 Million USD | -1158.17% |
| 2003 | -153 Thousand USD | -120.48% |
| 2002 | 747 Thousand USD | 552.73% |
| 2001 | -165 Thousand USD | -102.3% |
| 2000 | 7.16 Million USD | -17.91% |
| 1999 | 8.72 Million USD | 16.11% |
| 1998 | 7.51 Million USD | -13.61% |
| 1997 | 8.7 Million USD | 17.57% |
| 1996 | 7.4 Million USD | 1750.0% |
| 1995 | 400 Thousand USD | 300.0% |
| 1994 | 100 Thousand USD | -66.67% |
| 1993 | 300 Thousand USD | 400.0% |
| 1992 | -100 Thousand USD | -133.33% |
| 1991 | 300 Thousand USD | -57.14% |
| 1990 | 700 Thousand USD | -12.5% |
| 1989 | 800 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 9.82 Million USD | -19.49% |
| 2024 Q2 | 12.2 Million USD | 10.54% |
| 2024 Q1 | 11.03 Million USD | -6.91% |
| 2024 Q4 | 10.91 Million USD | 11.14% |
| 2024 FY | 10.91 Million USD | -7.93% |
| 2023 Q4 | 11.85 Million USD | -1.35% |
| 2023 Q3 | 12.01 Million USD | -15.18% |
| 2023 Q2 | 14.16 Million USD | 14.49% |
| 2023 Q1 | 12.37 Million USD | -16.04% |
| 2023 FY | 11.85 Million USD | -19.57% |
| 2022 Q2 | 9.15 Million USD | -4.95% |
| 2022 Q4 | 14.74 Million USD | 53.43% |
| 2022 FY | 14.74 Million USD | 28.37% |
| 2022 Q1 | 9.63 Million USD | -16.11% |
| 2022 Q3 | 9.6 Million USD | 4.94% |
| 2021 Q2 | 5.94 Million USD | 368.82% |
| 2021 Q1 | 1.26 Million USD | 381.75% |
| 2021 FY | 11.48 Million USD | 4265.78% |
| 2021 Q4 | 11.48 Million USD | 0.19% |
| 2021 Q3 | 11.46 Million USD | 92.93% |
| 2020 Q1 | 912 Thousand USD | 128.63% |
| 2020 Q2 | 1 Million USD | 10.53% |
| 2020 Q3 | 2.57 Million USD | 154.96% |
| 2020 Q4 | 263 Thousand USD | -89.77% |
| 2020 FY | 263 Thousand USD | 108.25% |
| 2019 Q3 | -4.94 Million USD | -23.64% |
| 2019 FY | -3.18 Million USD | 38.1% |
| 2019 Q4 | -3.18 Million USD | 35.61% |
| 2019 Q2 | -4 Million USD | -21.94% |
| 2019 Q1 | -3.28 Million USD | 36.23% |
| 2018 Q3 | -5.04 Million USD | 2.36% |
| 2018 Q1 | -5.75 Million USD | -40.72% |
| 2018 FY | -5.14 Million USD | -25.97% |
| 2018 Q4 | -5.14 Million USD | -1.94% |
| 2018 Q2 | -5.17 Million USD | 10.07% |
| 2017 Q4 | -4.08 Million USD | -14.58% |
| 2017 FY | -4.08 Million USD | -83.89% |
| 2017 Q1 | -2 Million USD | 9.68% |
| 2017 Q2 | -2.03 Million USD | -1.25% |
| 2017 Q3 | -3.56 Million USD | -75.49% |
| 2016 FY | -2.22 Million USD | -272.82% |
| 2016 Q3 | -1.37 Million USD | -191.53% |
| 2016 Q2 | -472 Thousand USD | -572.0% |
| 2016 Q4 | -2.22 Million USD | -61.48% |
| 2016 Q1 | 100 Thousand USD | 116.78% |
| 2015 Q4 | -596 Thousand USD | 56.37% |
| 2015 FY | -596 Thousand USD | 81.22% |
| 2015 Q1 | -3.59 Million USD | -13.33% |
| 2015 Q3 | -1.36 Million USD | 30.34% |
| 2015 Q2 | -1.96 Million USD | 45.47% |
| 2014 Q3 | -1.91 Million USD | -24.43% |
| 2014 Q2 | -1.53 Million USD | 15.15% |
| 2014 FY | -3.17 Million USD | -91.14% |
| 2014 Q4 | -3.17 Million USD | -66.13% |
| 2014 Q1 | -1.8 Million USD | -8.98% |
| 2013 Q2 | -2.54 Million USD | 18.43% |
| 2013 Q4 | -1.66 Million USD | 17.7% |
| 2013 FY | -1.66 Million USD | 50.27% |
| 2013 Q1 | -3.12 Million USD | 6.38% |
| 2013 Q3 | -2.01 Million USD | 20.87% |
| 2012 Q2 | -3.31 Million USD | 14.23% |
| 2012 Q3 | -4.01 Million USD | -21.15% |
| 2012 Q4 | -3.33 Million USD | 16.88% |
| 2012 FY | -3.33 Million USD | 6.18% |
| 2012 Q1 | -3.86 Million USD | -8.63% |
| 2011 Q4 | -3.55 Million USD | -39.09% |
| 2011 Q2 | -852 Thousand USD | 33.12% |
| 2011 Q1 | -1.27 Million USD | -41.71% |
| 2011 FY | -3.55 Million USD | -295.77% |
| 2011 Q3 | -2.55 Million USD | -200.23% |
| 2010 Q3 | -349 Thousand USD | -126.4% |
| 2010 Q2 | 1.32 Million USD | -28.19% |
| 2010 Q1 | 1.84 Million USD | -16.47% |
| 2010 FY | -899 Thousand USD | -140.79% |
| 2010 Q4 | -899 Thousand USD | -157.59% |
| 2009 Q3 | 2.93 Million USD | -23.01% |
| 2009 Q2 | 3.8 Million USD | -7.89% |
| 2009 Q1 | 4.13 Million USD | 19.14% |
| 2009 FY | 2.2 Million USD | -36.47% |
| 2009 Q4 | 2.2 Million USD | -24.8% |
| 2008 Q2 | 1.9 Million USD | 34.7% |
| 2008 FY | 3.46 Million USD | 60.45% |
| 2008 Q4 | 3.46 Million USD | 71.14% |
| 2008 Q1 | 1.41 Million USD | -34.55% |
| 2008 Q3 | 2.02 Million USD | 6.35% |
| 2007 Q4 | 2.16 Million USD | -32.75% |
| 2007 FY | 2.16 Million USD | -29.9% |
| 2007 Q3 | 3.21 Million USD | -0.68% |
| 2007 Q2 | 3.23 Million USD | 25.56% |
| 2007 Q1 | 2.57 Million USD | -16.41% |
| 2006 Q1 | -2.89 Million USD | -11.96% |
| 2006 Q2 | -2.17 Million USD | 24.75% |
| 2006 FY | 3.08 Million USD | 219.35% |
| 2006 Q4 | 3.08 Million USD | -3.63% |
| 2006 Q3 | 3.2 Million USD | 246.99% |
| 2005 Q3 | -2.25 Million USD | 11.2% |
| 2005 FY | -2.58 Million USD | -34.23% |
| 2005 Q2 | -2.54 Million USD | -29.2% |
| 2005 Q1 | -1.96 Million USD | -2.29% |
| 2005 Q4 | -2.58 Million USD | -14.39% |
| 2004 Q1 | 301 Thousand USD | 296.73% |
| 2004 Q2 | -88 Thousand USD | -129.24% |
| 2004 Q3 | -1.14 Million USD | -1200.0% |
| 2004 Q4 | -1.92 Million USD | -68.27% |
| 2004 FY | -1.92 Million USD | -1158.17% |
| 2003 FY | -153 Thousand USD | -120.48% |
| 2003 Q4 | -153 Thousand USD | -127.77% |
| 2003 Q3 | 551 Thousand USD | 25.8% |
| 2003 Q2 | 438 Thousand USD | 58.12% |
| 2003 Q1 | 277 Thousand USD | -62.92% |
| 2002 Q1 | 217 Thousand USD | 231.52% |
| 2002 Q2 | 426 Thousand USD | 96.31% |
| 2002 Q3 | 169 Thousand USD | -60.33% |
| 2002 Q4 | 747 Thousand USD | 342.01% |
| 2002 FY | 747 Thousand USD | 552.73% |
| 2001 Q2 | 6.46 Million USD | -4.83% |
| 2001 FY | -165 Thousand USD | -102.3% |
| 2001 Q3 | 5.93 Million USD | -8.17% |
| 2001 Q4 | -165 Thousand USD | -102.78% |
| 2001 Q1 | 6.79 Million USD | -5.2% |
| 2000 Q2 | 8.1 Million USD | -5.81% |
| 2000 Q3 | 7.47 Million USD | -7.67% |
| 2000 Q1 | 8.6 Million USD | -1.46% |
| 2000 FY | 7.16 Million USD | -17.91% |
| 2000 Q4 | 7.16 Million USD | -4.21% |
| 1999 Q4 | 8.72 Million USD | -5.14% |
| 1999 FY | 8.72 Million USD | 16.11% |
| 1999 Q1 | 8.1 Million USD | 7.77% |
| 1999 Q2 | 8.8 Million USD | 8.64% |
| 1999 Q3 | 9.2 Million USD | 4.55% |
| 1998 Q3 | 7.4 Million USD | -2.63% |
| 1998 Q4 | 7.51 Million USD | 1.57% |
| 1998 Q2 | 7.6 Million USD | -7.32% |
| 1998 Q1 | 8.2 Million USD | -5.75% |
| 1998 FY | 7.51 Million USD | -13.61% |
| 1997 Q2 | 9.4 Million USD | 6.82% |
| 1997 Q4 | 8.7 Million USD | -11.22% |
| 1997 Q3 | 9.8 Million USD | 4.26% |
| 1997 FY | 8.7 Million USD | 17.57% |
| 1997 Q1 | 8.8 Million USD | 18.92% |
| 1996 FY | 7.4 Million USD | 1750.0% |
| 1996 Q3 | 7.2 Million USD | 0.0% |
| 1996 Q1 | 6.7 Million USD | 1575.0% |
| 1996 Q2 | 7.2 Million USD | 7.46% |
| 1996 Q4 | 7.4 Million USD | 2.78% |
| 1995 Q2 | 300 Thousand USD | 200.0% |
| 1995 Q3 | 300 Thousand USD | 0.0% |
| 1995 Q4 | 400 Thousand USD | 33.33% |
| 1995 FY | 400 Thousand USD | 300.0% |
| 1995 Q1 | 100 Thousand USD | 0.0% |
| 1994 Q3 | - USD | -100.0% |
| 1994 Q4 | 100 Thousand USD | 0.0% |
| 1994 Q2 | 100 Thousand USD | -66.67% |
| 1994 FY | 100 Thousand USD | -66.67% |
| 1994 Q1 | 300 Thousand USD | 0.0% |
| 1993 FY | 300 Thousand USD | 400.0% |
| 1993 Q4 | 300 Thousand USD | 0.0% |
| 1993 Q3 | - USD | 100.0% |
| 1993 Q2 | -100 Thousand USD | 50.0% |
| 1993 Q1 | -200 Thousand USD | -100.0% |
| 1992 FY | -100 Thousand USD | -133.33% |
| 1992 Q3 | 1 Million USD | 0.0% |
| 1992 Q4 | -100 Thousand USD | -110.0% |
| 1991 Q4 | 300 Thousand USD | 0.0% |
| 1991 FY | 300 Thousand USD | -57.14% |
| 1990 Q4 | 700 Thousand USD | 0.0% |
| 1990 FY | 700 Thousand USD | -12.5% |
| 1989 FY | 800 Thousand USD | 0.0% |
| 1989 Q4 | 800 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | -322.937% |
| AngioDynamics, Inc. | -70.14 Million USD | 115.563% |
| AtriCure, Inc. | -9.81 Million USD | 211.206% |
| Avinger, Inc. | 10.12 Million USD | -7.866% |
| Azenta, Inc. | -618.47 Million USD | 101.765% |
| BioLife Solutions, Inc. | 7.25 Million USD | -50.503% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 99.554% |
| Daxor Corporation | 755.65 Thousand USD | -1344.567% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | 842.585% |
| Femasys Inc. | -15.01 Million USD | 172.7% |
| GlucoTrack, Inc. | -4.29 Million USD | 354.097% |
| Harvard Bioscience, Inc. | 38.49 Million USD | 71.639% |
| Hologic, Inc. | 374.4 Million USD | 97.084% |
| ICU Medical, Inc. | 1.45 Billion USD | 99.247% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 100.41% |
| KORU Medical Systems, Inc. | -7.03 Million USD | 255.12% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | 310.978% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 354.604% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 354.604% |
| Masimo Corporation | 804 Million USD | 98.642% |
| Microbot Medical Inc. | -2.28 Million USD | 577.515% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | 213.759% |
| Merit Medical Systems, Inc. | 302.22 Million USD | 96.388% |
| Nephros, Inc. | -2.47 Million USD | 541.764% |
| NovoCure Limited | 355.42 Million USD | 96.929% |
| NEXGEL, Inc. | 98 Thousand USD | -11038.776% |
| NEXGEL, Inc. | 98 Thousand USD | -11038.776% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | 81.516% |
| OraSure Technologies, Inc. | -276.9 Million USD | 103.942% |
| Pulse Biosciences, Inc. | -35.22 Million USD | 130.993% |
| Predictive Oncology Inc. | -5.87 Million USD | 285.904% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | -260.361% |
| QuidelOrtho Corporation | 2.49 Billion USD | 99.563% |
| Repligen Corporation | -39.51 Million USD | 127.622% |
| Sanara MedTech Inc. | 6.64 Million USD | -64.277% |
| STAAR Surgical Company | -147.2 Million USD | 107.416% |
| Sharps Technology, Inc. | -3.01 Million USD | 462.308% |
| Utah Medical Products, Inc. | -92.52 Million USD | 111.798% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 99.444% |
| Jin Medical International Ltd. | -2.81 Million USD | 487.572% |